Disease Areas
Through our extensive network, we ethically source underrepresented biospecimens from diverse African communities and ethnic groups. Partnering with over 300 health facilities, we aim to advance understanding and therapies in various disease areas.
Genetic disorders are conditions caused by abnormalities in an individual’s DNA. These disorders can be inherited from parents or occur spontaneously. In Africa, the prevalence of genetic disorders is influenced by the continent’s diverse population and genetic variations among different ethnic groups. Ongoing research is crucial to understanding the genetic diversity and factors influencing the occurrence of these disorders in the continent’s diverse population.
• Sickle Cell Disease (SCD)
• Thalassemia
• Albinism
• Neurogenetic Disorders
Oncological diseases, encompassing various forms of cancer, present a significant health challenge globally. In Africa, cancers continue to impose a considerable health burden, with factors such as population growth, aging, and environmental exposures, contributing to the increasing prevalence rate. At MyAfroDNA, we have access to a wide array of ethically sourced biospecimens from different cancer types.
- Breast cancer
- Prostate cancer
- Cervical cancer
- Colorectal cancer
- Head and neck
- Other cancers
Neurologic diseases encompass a spectrum of conditions affecting the nervous system. MyAfroDNA plays a vital role in advancing research by facilitating the recruitment of patients across various neurologic disease types in the African population. Our platform ensures access to a diverse pool of ethically sourced biospecimens, contributing to the understanding and treatment of neurologic disorders in the region.
• Alzheimer
• Parkinson
Respiratory diseases, affecting the lungs and airways, pose significant health challenges globally. In Africa, limited access to healthcare, environmental factors, and infectious agents contribute to the prevalence of these diseases in the region. MyAfroDNA is committed to advancing respiratory disease research by facilitating the recruitment of patients across various disease types in the African population.
• Asthma
• COPD
• Tuberculosis
Metabolic and endocrinology diseases, affecting processes like metabolism and hormone regulation, are significant health challenges worldwide. In Africa, factors such as lifestyle changes and genetic diversity contribute to the prevalence of the conditions. MyAfroDNA actively supports research in metabolic and endocrinology diseases by facilitating the recruitment of patients across various disease types in the African population.
• Chronic kidney disease
• Diabetes
• Sickle cell anemia
• Thyroid disorders
Ophthalmology diseases, encompassing a range of conditions affecting the eyes and vision, are significant health issues globally. In Africa, limited access to eye care, genetic factors, environmental factors, and infectious agents contribute to the prevalence of eye diseases in the region. MyAfroDNA actively supports ophthalmology research by aiding in the recruitment of patients across various disease types in the African population.
• Glaucoma
• Age-related macular degeneration
• Cataract
Cardiovascular diseases (CVDs), affecting the heart and blood vessels, pose a significant global health challenge. In Africa, the prevalence of cardiovascular diseases are on the rise due to factors like lifestyle changes, urbanization, and genetic predisposition. MyAfroDNA is committed to advancing cardiovascular disease research by facilitating the recruitment of patients across various disease types in the African population.
• Hypertension
• Cardiomyopathy
• Stroke
• Heart failure
Autoimmune diseases, where the immune system mistakenly targets and attacks the body’s own tissues, are a complex group of disorders that present complex health challenges globally. In Africa, the prevalence of autoimmune diseases is influenced by genetic factors, environmental triggers, and the overall immune landscape. MyAfroDNA is dedicated to advancing autoimmune disease research by facilitating the recruitment of patients across various disease types in the African population.
• Rheumatoid arthritis
• Systemic lupus erythematosus (SLE)
• Psoriasis
Gynecologic diseases, typically affect the female reproductive system and present a diverse array of health challenges. In Africa, the prevalence of Gynecology/Obstetrics (OB-GYN) diseases is influenced by multifactorial factors. MyAfroDNA is actively involved in advancing OB-GYN disease research by facilitating the recruitment of patients across various disease types in the African population. We provide access to a diverse pool of ethically sourced biospecimens, enabling researchers to explore and address the unique aspects of OB-GYN diseases.
• Endometriosis
• PCOS
• Uterine fibroids
• Pre-eclampsia
Tropical diseases, typically found in regions with warm climates, present a diverse array of health challenges. In Africa, the prevalence of tropical diseases is influenced by factors such as climate, environmental conditions, and socio-economic factors. MyAfroDNA is actively involved in advancing tropical disease research by facilitating the recruitment of patients across various disease types in the African population. We provide access to a diverse pool of ethically sourced biospecimens, enabling researchers to explore and address the unique aspects of tropical diseases. By connecting researchers with a broad patient community, MyAfroDNA plays a crucial role in advancing treatments and preventive measures for tropical diseases in the region.
• Malaria
• HIV
• Hepatitis B
• Hepatitis C
• Liver diseases
• Dengue fever
• Chikungunya
• Onchocerciasis
• Schistosomiasis
African Biospecimens
Leverage our diverse pool of ethically sourced African biospecimens, accompanied by comprehensive datasets to advance your research efforts.
- Blood-derived Products
Whole blood
Plasma
Buffy coat
PBMCs
Plasma
Serum
- Other Biofluids
Swabs
Saliva
Stool
Urine
- Tissue
Biopsy
FFPE
Human African Bioresources
Interrogate clinical bioresources from sparsely characterized African Ethnic Groups to make some novel and therapeutically relevant discoveries.
